GlaxoSmithKline v. The U.S. Patent Office

Representative Appellate Matter

Representing GlaxoSmithKline, sustained an injunction against portions of the sweeping patent reform rules proposed for implementaton by the U.S. PTO, Federal Circuit, Spring 2009.